The cell signaling global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cell Signaling Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The cell signaling market size has grown strongly in recent years. It will grow from $4.25 billion in 2023 to $4.59billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the growth of the pharmaceutical and biotechnology industries, expansion of regenerative medicine, aging population, personalized medicine initiatives, and rising burden of chronic diseases.
The cell signaling market size is expected to see strong growth in the next few years. It will grow to $6.32 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of precision medicine, government support, increasing research funding, role in development and homeostasis, and rise in endocrine-related conditions. Major trends in the forecast period include technological advancements, machine learning and artificial intelligence to signal analysis, use of bioprinting technology, next-generation sequencing, and single-cell analysis technique.
Scope Of Cell Signaling MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cell Signaling Market Overview
Market Drivers –
The increasing prevalence of chronic diseases is expected to propel the growth of the cell signaling market going forward. Chronic diseases are long-lasting medical conditions that progress slowly and persist for extended periods, often for years or even a lifetime. These conditions are characterized by their prolonged duration and may require ongoing management and treatment to control symptoms, prevent complications, and maintain quality of life. The prevalence of chronic disease is due to an aging population, unhealthy lifestyles, and the accessibility and infrastructure of healthcare. Cell signaling research provides valuable insights and tools for understanding, diagnosing, treating, and preventing chronic diseases, offering hope for improved outcomes and quality of life for affected individuals. For instance, in January 2023, according to the National Library of Medicine, a US-based biomedical library, the number of people 50 years of age and older having at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase. Therefore, the increasing prevalence of chronic diseases is driving the growth of the cell signaling market.
Market Trends –
Major companies operating in the cell signaling market are focused on developing innovative technologies, such as immunohistochemistry (IHC) assays, to strengthen their position in the market. Immunohistochemistry (IHC) assays are laboratory techniques to detect and visualize specific proteins or antigens within tissue samples. For instance, in September 2023, Cell Signaling Technology (CST), a US-based life sciences discovery technology company, announced the launch of SignalStar Multiplex IHC technology, an innovative tool for a method for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays. This innovative technology allows researchers to detect multiple targets simultaneously in formalin-fixed, paraffin-embedded (FFPE) tissues with high sensitivity and specificity. It utilizes a combination of antibodies, oligonucleotides, and fluorophores to amplify the antibody signal, enabling the detection of targets, even those with low expression levels of up to eight proteins in a single tissue.
The cell signaling market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Signaling Type: Endocrine Signaling, Paracrine Signaling , Autocrine Signaling , Synaptic Signaling Source, Other Signaling Types
3) By Pathway: Akt Signaling Pathway, AMPK Signaling Pathway, ErbB/HER Signaling Pathway , Other Signaling Pathways
4) By Technology: Microscopy, Western Blotting, Flow Cytometry, Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Mass Spectrometry, Other Technologies
5) By Application: Research Applications, Medical Applications
Regional Insights –
North America was the largest region in the cell signaling market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell signaling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the cell signaling market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc. , Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corporation, Miltenyi Biotec, Promega Corporation, Janssen Pharmaceuticals Inc., Abcam plc, Horizon Discovery Ltd., Cell Signaling Technology Inc., Cisbio Bioassays, Rockland Immunochemicals Inc.
Table of Contents
1. Executive Summary2. Cell Signaling Market Report Structure3. Cell Signaling Market Trends And Strategies4. Cell Signaling Market – Macro Economic Scenario5. Cell Signaling Market Size And Growth…..27. Cell Signaling Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow Us On: